Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, December 23, 2020
Abzena has appointed Kimball Hall, Chief Operating Officer at Abzena as President in addition to her COO role.
read more
Wednesday, December 23, 2020
AvKARE is voluntarily recalling one lot of Sildenafil 100 mg tablets and one lot of Trazodone 100mg tablets to the consumer level.
read more
Wednesday, December 23, 2020
The GCSA has launched with a commitment to increase clinical research and trial capacity and quality in the UK as well as Globally.
read more
Monday, December 28, 2020
Compugen has announced progress from its ongoing license agreement with AstraZeneca under which the program has achieved a preclinical milestone.
read more
Monday, December 28, 2020
Nordic Capital and Astorg announced an agreement to jointly acquire Cytel from New Mountain Capital.
read more
Monday, December 28, 2020
Orifarm and NNIT have signed a contract for the delivery of end-to-end IT services in connection with Orifarm’s acquisition of a portfolio of select OTC and prescription pharmaceutical products from Takeda.
read more
Monday, December 28, 2020
Ajinomoto Bio-Pharma Services and Revance Therapeutics have announced a commercial manufacturing agreement for the supply of DaxibotulinumtoxinA for Injection.
read more
Monday, December 28, 2020
Gattefossé is investing 30 million euros in its industrial operations and announces the construction of a new manufacturing plant in Lufkin, Texas.
read more
Monday, December 28, 2020
BioMedion has announced the acquisition of the Compliance Division of arivis AG, a provider of regulatory software and biomedical 3D and big image data software solutions.
read more
Tuesday, December 29, 2020
Immutep has prioritized the recommencement of the process of scaling up the manufacturing of its lead product candidate eftilagimod alpha.
read more
Tuesday, December 29, 2020
vTv Therapeutics has entered into a licensing agreement with Anteris Bio for worldwide rights to vTv’s novel clinical-stage Nrf2 activator compound, HPP971.
read more
Tuesday, December 29, 2020
Harbour BioMed and Utrecht University announced that they licensed to AbbVie their fully human, SARS-CoV-2 neutralizing antibody, 47D11 and program, for the prevention and treatment of COVID-19.
read more
Tuesday, December 29, 2020
Quantum Genomics has signed a strategic contract with Delpharm for the manufacture of the next clinical batches of firibastat tablets on an industrial scale and the establishment of production lines for future commercial batches.
read more
Wednesday, December 30, 2020
Samsung Biologics announced John Rim as its President and CEO.
read more
Wednesday, December 30, 2020
SAI is voluntarily recalling Paroex Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 12/31/2020 – 9/30/2022 to the consumer level.
read more